As of 2025-05-04, the Fair Value of PharmaCyte Biotech Inc (PMCB) is 58.82 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.21 USD, the upside of PharmaCyte Biotech Inc is 4,760.90%.
With the market price of 1.21 USD and our fair value calculation, PharmaCyte Biotech Inc (PMCB) is a good investment. Investing in PMCB stocks now will result in a potential gain of 4,760.90%.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-04-30 | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 5Y Avg | |
| Net income | -3.83 | -3.55 | -4.24 | -4.32 | 0.33 | -3.12 |
| YoY growth | 5.90% | 7.31% | -19.44% | -1.89% | 107.73% | 19.92% |
| Market Cap (mil) | 8.30 |
| P/E | 0.41x |
| Forward P/E | 24.15x |
| EPS | 2.95 |
| Avg earnings growth rate | 19.92% |
| TTM earnings | 20.25 |